Fosaprepitant

Fosaprepitant

Clinical data
Dosage
Fosaprepitant 150 mg IV 1 vial of 150 mg/vial More information about this dose Weight kglbg Height cmminft Age yrmowk SexFM Indication  Indication: Postoperative nausea & vomiting Route  Route: Intravenous Preparation  Preparation: 150 mg/vial Murakami C, Kakuta N, Kume K, Sakai Y, Kasai A, Oyama T, Tanaka K, Tsutsumi YM. A Comparison of Fosaprepitant and Ondansetron for Preventing Postoperative Nausea and Vomiting in Moderate to High Risk Patients: A Retrospective Database Analysis. Biomed Res Int. 2017;2017:5703528. doi: 10.1155/2017/5703528. Epub 2017 Dec 19. PMID: 29410964; PMCID: PMC5749222.
Pharmacodynamics
Pharmacokinetics
Physical and chemical data
Article quality
Editor rating	Unrated
User likes	0

Provide a brief summary of this drug here.